Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 5:07 pm Sale | 2023-12-31 | 13G | Nanobiotix S.A. NBTX | Artal Participations S.a r.l | 0 0.000% | -3,069,034 (Position Closed) | Filing History |
| 2024-02-09 5:06 pm Sale | 2023-12-31 | 13G | Morphic Holding, Inc. MORF | Artal Participations S.a r.l | 2,138,188 4.300% | -11,812 (-0.55%) | Filing History |
| 2024-02-09 5:06 pm Sale | 2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | Artal Participations S.a r.l | 138,955 5.700% | -1 (-0.00%) | Filing History |
| 2024-02-09 5:05 pm Purchase | 2023-12-31 | 13G | Silence Therapeutics plc SLN | Artal Participations S.a r.l | 9,000,000 7.800% | 1,500,000 (+20.00%) | Filing History |
| 2024-02-09 5:04 pm Purchase | 2023-12-31 | 13G | CAVA Group, Inc. CAVA | Artal Participations S.a r.l | 32,007,990 28.200% | 32,007,990 (New Position) | Filing History |
| 2024-02-09 5:03 pm Purchase | 2023-12-31 | 13G | GlycoMimetics, Inc. GLYC | Artal Participations S.a r.l | 85,891 13.300% | 20,153 (+30.66%) | Filing History |
| 2024-01-22 4:31 pm Purchase | 2024-01-11 | 13G | Solid Biosciences Inc. SLDB | Artal Participations S.a r.l | 2,717,538 7.300% | 2,717,538 (New Position) | Filing History |
| 2024-01-11 4:30 pm Purchase | 2023-12-14 | 13G | Gossamer Bio, Inc. GOSS | Artal Participations S.a r.l | 13,108,880 5.800% | 13,108,880 (New Position) | Filing History |
| 2023-11-13 4:30 pm Purchase | 2023-11-03 | 13G | Korro Bio, Inc. KRRO | Artal Participations S.a r.l | 418,605 5.200% | 418,605 (New Position) | Filing History |
| 2023-09-01 4:12 pm Purchase | 2023-08-24 | 13G | Silence Therapeutics plc SLN | Artal Participations S.a r.l | 7,500,000 6.800% | 7,500,000 (New Position) | Filing History |
| 2023-06-12 4:30 pm Purchase | 2023-06-01 | 13G | Cartesian Therapeutics, Inc. RNAC | Artal Participations S.a r.l | 340,233 6.600% | 340,233 (New Position) | Filing History |
| 2023-03-31 4:15 pm Purchase | 2023-03-23 | 13G | Harpoon Therapeutics, Inc. HARP | Artal Participations S.a r.l | 234,744 6.100% | 234,744 (New Position) | Filing History |
| 2023-02-13 5:18 pm Purchase | 2023-02-09 | 13G | GlycoMimetics, Inc. GLYC | Artal Participations S.a r.l | 65,738 12.500% | 65,738 (New Position) | Filing History |
| 2023-02-10 7:56 pm Purchase | 2022-09-28 | 13G | Morphic Holding, Inc. MORF | Artal Participations S.a r.l | 2,150,000 5.600% | 564,951 (+35.64%) | Filing History |
| 2023-02-10 7:53 pm Purchase | 2022-12-31 | 13G | SQZ Biotechnologies Company SQZB | Artal Participations S.a r.l | 160,631 5.500% | 160,631 (New Position) | Filing History |
| 2023-02-10 7:41 pm Purchase | 2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Artal Participations S.a r.l | 1,463,829 7.200% | 1,113,829 (+318.24%) | Filing History |
| 2023-02-10 7:36 pm Sale | 2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 2,243,352 6.300% | -42,222 (-1.85%) | Filing History |
| 2023-02-10 7:34 pm Sale | 2022-12-31 | 13G | Omega Alpha SPAC OMEG | Artal Participations S.a r.l | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2023-02-10 7:33 pm Purchase | 2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK | Artal Participations S.a r.l | 10,555,278 19.800% | 230,236 (+2.23%) | Filing History |
| 2023-02-10 7:31 pm Unchanged | 2022-12-31 | 13G | NexImmune, Inc. NEXI | Artal Participations S.a r.l | 48,000 4.600% | 0 (Unchanged) | Filing History |